Cargando…

Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid

BACKGROUND: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. Biomarkers that can help monitor the progression of PD or response to disease-modifying agents will be invaluable in making appropriate therapeutic decisions. Further, biomarkers that could be used to disti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na, Chan Hyun, Sathe, Gajanan, Rosenthal, Liana S., Moghekar, Abhay R., Dawson, Valina L., Dawson, Ted M., Pandey, Akhilesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197159/ https://www.ncbi.nlm.nih.gov/pubmed/32390785 http://dx.doi.org/10.1186/s12014-020-09277-8

Ejemplares similares

Phosphotyrosine profiling of human cerebrospinal fluid
por: Sathe, Gajanan, et al.
Publicado: (2018)

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
por: Poggiolini, Ilaria, et al.
Publicado: (2021)

Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation
por: Thomas, Bobby, et al.
Publicado: (2011)

Correction: Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation
por: Thomas, Bobby, et al.
Publicado: (2012)

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
por: Kruse, Niels, et al.
Publicado: (2018)

Determinants of seeding and spreading of α-synuclein pathology in the brain
por: Henrich, Martin T., et al.
Publicado: (2020)

Implications of alpha-synuclein nitration at tyrosine 39 in methamphetamine-induced neurotoxicity in vitro and in vivo
por: Qiao, Hong-Hua, et al.
Publicado: (2019)

Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders
por: Constantinides, Vasilios C., et al.
Publicado: (2021)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
por: Dolatshahi, Mahsa, et al.
Publicado: (2018)

Synovial fluid proteome in rheumatoid arthritis
por: Bhattacharjee, Mitali, et al.
Publicado: (2016)

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
por: Ge, Preston, et al.
Publicado: (2020)

Pharmacologic inhibition of MIF nuclease: A new treatment paradigm to treat cell death
por: Biswas, Devanik, et al.
Publicado: (2022)

Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid
por: Kakuda, Keita, et al.
Publicado: (2019)

Associations of sleep characteristics with alpha‐synuclein in cerebrospinal fluid in older adults
por: Wang, Xiao‐Tong, et al.
Publicado: (2020)

Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders
por: Agnello, Luisa, et al.
Publicado: (2022)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
por: Gu, Hao, et al.
Publicado: (2021)

Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study
por: Kamalian, Aida, et al.
Publicado: (2023)

The interplay of microRNA and neuronal activity in health and disease
por: Eacker, Stephen M., et al.
Publicado: (2013)

Targeting Parthanatos in Ischemic Stroke
por: Koehler, Raymond C., et al.
Publicado: (2021)

Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease
por: Wang, Shijie, et al.
Publicado: (2022)

Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological α-synuclein
por: Sterling, Jacob K., et al.
Publicado: (2022)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study
por: Unterberger, Ursula, et al.
Publicado: (2014)

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
por: Twohig, Daniel, et al.
Publicado: (2018)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

Longitudinal Analyses of Cerebrospinal Fluid α-Synuclein in Prodromal and Early Parkinson’s Disease
por: Mollenhauer, Brit, et al.
Publicado: (2019)

Relevance of retrovirus quantification in cerebrospinal fluid for neurologic diagnosis
por: Rosadas, Carolina, et al.
Publicado: (2015)

The cell biology of Parkinson’s disease
por: Panicker, Nikhil, et al.
Publicado: (2021)

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid(42) and DJ-1 in Human Cerebrospinal Fluid
por: Kruse, Niels, et al.
Publicado: (2016)

DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease
por: Yazar, Volkan, et al.
Publicado: (2023)

Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
por: Xiong, Yulan, et al.
Publicado: (2017)

Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia
por: Panicker, Nikhil, et al.
Publicado: (2019)

Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders
por: Li, Jie-Qiong, et al.
Publicado: (2020)

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
por: Perra, Daniela, et al.
Publicado: (2021)

Cerebrospinal fluid α synuclein concentrations in patients with positive AD biomarkers and extrapyramidal symptoms
por: Winkel, Izabela, et al.
Publicado: (2021)

Quantification of Amino Acid Neurotransmitters in Cerebrospinal Fluid of Patients with Neurocysticercosis
por: Camargo, José Augusto, et al.
Publicado: (2015)

Image Analysis Techniques for In Vivo Quantification of Cerebrospinal Fluid Flow
por: Kim, Daehyun, et al.
Publicado: (2023)

Quantification of Bile Acids in Cerebrospinal Fluid: Results of an Observational Trial
por: Harnisch, Lars-Olav, et al.
Publicado: (2023)

Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer
por: Gondkar, Kirti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h581oi1080oebr0gvgjoclpcqp